EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Reconsidering “low‐dose”—Impacts of oral estrogen exposure during preimplantation embryo development

Meret Schmidhauser iD, Anna-Katharina Hankele iD, Susanne E Ulbrich iD

Molecular Reproduction and Development · 2023

DOI: 10.1002/mrd.23675 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Reproduction and Development, 2023. Verfasst von Meret Schmidhauser und 2 weiteren Autor:innen. Beteiligte Einrichtung: ETH Zurich, Animal Physiology, Institute of Agricultural Sciences, Zurich, Switzerland. Hauptthemen laut MEDLINE: Estrogens, Estrone. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 135 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Perturbations of estrogen signaling during developmental stages of high plasticity may lead to adverse effects later in life. Endocrine‐disrupting chemicals (EDC) are compounds that interfere with the endocrine system by particularly mimicking the action of endogenous estrogens as functional agonists or antagonists. EDCs compose synthetic and naturally occurring compounds discharged into the environment, which may be taken up via skin contact, inhalation, orally due to contaminated food or water, or via the placenta during in utero development. Although estrogens are efficiently metabolized by the liver, the role of circulating glucuro‐ and/or sulpho‐conjugated estrogen metabolites in the body has not been fully addressed to date. Particularly, the role of intracellular cleavage to free functional estrogens could explain the hitherto unknown mode of action of adverse effects of EDC at very low concentrations currently considered safe. We summarize and discuss findings on estrogenic EDC with a focus on early embryonic development to highlight the need for reconsidering low dose effects of EDC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EstrogensEstroneFemalePregnancyHumansSignal TransductionEmbryonic DevelopmentPlacenta

Stichwörter der Autor:innen

embryoestrogenestrogen-disrupting chemicalsglucuro-/sulpho-conjugated estrogen metabolitelow dosepreimplantation

Substanzen

EstrogensEstrone

Autor:innen und Institutionen

  • ETH Zurich, Animal Physiology, Institute of Agricultural Sciences, Zurich, Switzerland.

ORCID-Profile: Meret Schmidhauser, Anna-Katharina Hankele, Susanne E Ulbrich

Zitieren

APA

Schmidhauser, M., Hankele, A. K., & Ulbrich, S. E. (2023). Reconsidering “low‐dose”—Impacts of oral estrogen exposure during preimplantation embryo development. Molecular Reproduction and Development. https://doi.org/10.1002/mrd.23675

Vancouver

Schmidhauser M, Hankele AK, Ulbrich SE. Reconsidering “low‐dose”—Impacts of oral estrogen exposure during preimplantation embryo development. Molecular Reproduction and Development. 2023. doi:10.1002/mrd.23675

BibTeX
@article{Schmidhauser2023,
  author = {Schmidhauser, Meret and Hankele, Anna-Katharina and Ulbrich, Susanne E},
  title = {Reconsidering “low‐dose”—Impacts of oral estrogen exposure during preimplantation embryo development},
  journal = {Molecular Reproduction and Development},
  year = {2023},
  doi = {10.1002/mrd.23675}
}
Kostenlos starten →